These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26549430)

  • 1. Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives.
    Jadhavar PS; Vaja MD; Dhameliya TM; Chakraborti AK
    Curr Med Chem; 2015; 22(38):4379-97. PubMed ID: 26549430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
    Kamal A; Shetti RV; Azeeza S; Swapna P; Khan MN; Khan IA; Sharma S; Abdullah ST
    Eur J Med Chem; 2011 Mar; 46(3):893-900. PubMed ID: 21272965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.
    Balasubramanian V; Solapure S; Iyer H; Ghosh A; Sharma S; Kaur P; Deepthi R; Subbulakshmi V; Ramya V; Ramachandran V; Balganesh M; Wright L; Melnick D; Butler SL; Sambandamurthy VK
    Antimicrob Agents Chemother; 2014; 58(1):495-502. PubMed ID: 24189255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial activities of oxazolidinones: a review.
    Sood R; Bhadauriya T; Rao M; Gautam R; Malhotra S; Barman TK; Upadhyay DJ; Rattan A
    Infect Disord Drug Targets; 2006 Dec; 6(4):343-54. PubMed ID: 17168800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates.
    Patel RV; Keum YS; Park SW
    Mini Rev Med Chem; 2015; 15(14):1174-86. PubMed ID: 26156417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
    Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
    Vera-Cabrera L; Castro-Garza J; Rendon A; Ocampo-Candiani J; Welsh O; Choi SH; Blackwood K; Molina-Torres C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4351-3. PubMed ID: 16189119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in oxazolidinones as antituberculosis agents.
    Lu H; Wang H; Zhao H; Zhang D
    Future Med Chem; 2022 Aug; 14(15):1149-1165. PubMed ID: 35866418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
    Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
    Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.
    Rakesh ; Bruhn DF; Scherman MS; Singh AP; Yang L; Liu J; Lenaerts AJ; Lee RE
    Bioorg Med Chem Lett; 2016 Jan; 26(2):388-391. PubMed ID: 26711150
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    McNeil MB; Dennison DD; Shelton CD; Parish T
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
    Zhang M; Sala C; Dhar N; Vocat A; Sambandamurthy VK; Sharma S; Marriner G; Balasubramanian V; Cole ST
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3217-23. PubMed ID: 24663022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
    Richter E; Rüsch-Gerdes S; Hillemann D
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
    Yip PC; Kam KM; Lam ET; Chan RC; Yew WW
    Int J Antimicrob Agents; 2013 Jul; 42(1):96-7. PubMed ID: 23684005
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria.
    Zhuang Z; Wan D; Ding J; He S; Zhang Q; Wang X; Yuan Y; Lu Y; Ding CZ; Lynch AS; Upton AM; Cooper CB; Denny WA; Ma Z
    Molecules; 2020 May; 25(10):. PubMed ID: 32456032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
    Tasneen R; Betoudji F; Tyagi S; Li SY; Williams K; Converse PJ; Dartois V; Yang T; Mendel CM; Mdluli KE; Nuermberger EL
    Antimicrob Agents Chemother; 2016 Jan; 60(1):270-7. PubMed ID: 26503656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
    Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
    New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.
    Makafe GG; Cao Y; Tan Y; Julius M; Liu Z; Wang C; Njire MM; Cai X; Liu T; Wang B; Pang W; Tan S; Zhang B; Yew WW; Lamichhane G; Guo J; Zhang T
    Antimicrob Agents Chemother; 2016 May; 60(5):3202-6. PubMed ID: 26953211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and intracellular activity of 4-substituted piperazinyl phenyl oxazolidinone analogues against Mycobacterium tuberculosis.
    Wang D; Zhao Y; Liu Z; Lei H; Dong M; Gong P
    J Antimicrob Chemother; 2014 Jun; 69(6):1711-4. PubMed ID: 24526515
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches.
    Kumar A; Karkara BB; Panda G
    Chem Biol Drug Des; 2021 Nov; 98(5):787-827. PubMed ID: 34397161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.